China Resources Pharmaceutical Group Limited (HKG:3320)
Hong Kong · Delayed Price · Currency is HKD 5.29
+0.03 (0.57%)
Aug 15, 2025, 4:08 PM HKT
HKG:3320 Market Cap
HKG:3320 has a market cap or net worth of 33.23 billion as of August 15, 2025. Its market cap has increased by 0.19% in one year.
Market Cap
33.23B
Enterprise Value
132.42B
Revenue
274.21B
Ranking
n/a
PE Ratio
9.37
Stock Price
5.29
Market Cap Chart
Since October 28, 2016, HKG:3320's market cap has decreased from 55.61B to 33.23B, a decrease of -40.24%. That is a compound annual growth rate of -5.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 33.23B | -7.19% |
| Dec 31, 2024 | 35.81B | 11.11% |
| Dec 29, 2023 | 32.23B | -18.83% |
| Dec 30, 2022 | 39.71B | 78.03% |
| Dec 31, 2021 | 22.30B | -10.80% |
| Dec 31, 2020 | 25.00B | -44.97% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 248.84B |
| Hansoh Pharmaceutical Group Company | 214.64B |
| JD Health International | 172.49B |
| Innovent Biologics | 149.52B |
| Akeso | 140.47B |
| Sino Biopharmaceutical | 133.96B |
| WuXi Biologics | 120.32B |
| CSPC Pharmaceutical Group | 114.79B |